Advanced search
Publication Cover
Journal of Blood Medicine Volume 14, 2023 - Issue
Submit an article Journal homepage
314
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Prevalence of Inherited Thrombophilia in Women with Recurrent Pregnancy Loss During the First Trimester of Pregnancy

Tagwa Yousif Elsayed Yousif1 Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, Jazan University, Gizan, 45142, Saudi Arabia;2 Department of Medical Laboratory Sciences, College of Medical Laboratory Sciences, Alneelian university, Khartoum, SudanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0238-8083
ORCID Icon
Pages 253-259 | Received 30 Dec 2022, Accepted 31 Mar 2023, Published online: 05 Apr 2023

References

  • Kupferminc MJ. Thrombophilia and pregnancy. Reprod. Biol Endocrinol. 2003;1(1):111. doi:10.1186/1477-7827-1-111
  • Brill-Edwards P, Ginsberg JS, Gent M. Safety of withholding antepartum heparin in women with a previous episode of venous thromboembolism. N Engl J Med. 2000;343(20):1439–1444. doi:10.1056/nejm200011163432002
  • Martinelli I. Thromboembolism in women. Semin Thromb Hemost. 2006;32(7):709–715. doi:10.1055/s-2006-951455
  • Robertson L, Wu O, Langhorne P, et al. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Br J Haematol. 2005;132(11):171–196. doi:10.3310/hta10110
  • Simcox LE, Ormesher L, Tower C, Greer IA. Thrombophilia and Pregnancy Complications. Int J Mol Sci. 2015;16(12):28418–28428. doi:10.3390/ijms161226104
  • Tait RC, Walker ID, Perry DJ, et al. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol. 1994;87(1):106–112. doi:10.1111/j.1365-2141.1994.tb04878.x
  • Gerhardt A, Scharf RE, Beckman MW. Prothrombin and factor V mutations in women with thrombosis during pregnancy and the puerperium. N Engl J Med. 2000;342(6):374–380. doi:10.1056/NEJM200002103420602
  • Robertson L, Wu O, Langhorne P, et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol. 2006;132(2):171–196. doi:10.1111/j.1365-2141.2005.05847.x
  • Liu X, Chen Y, Ye C, et al. Hereditary thrombophilia and recurrent pregnancy loss: a systematic review and meta-analysis. Int J Mol Sci. 2021;36(5):1213–1229. doi:10.1093/humrep/deab010
  • Kluijtmans LA, van den Heuvel LP, Boers H, et al. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet. 1996;58(1):35–41. PMID: 8554066.
  • Patnaik MM, Haddad T, Morton CT. Pregnancy and thrombophilia. Semin Respir Crit Care Med. 2007;28(5):753–765. doi:10.1586/14779072.5.4.753
  • Walker ID. Thrombophilia in pregnancy. J Clin Pathol. 2000;53(8):573–580. PMID: 11002758. doi:10.1136/jcp.53.8.573
  • Bates SM. Management of pregnant women with thrombophilia or a history of venous thromboembolism. Hematology Am Soc Hematol Educ Program. 2007;1(1):143–150. doi:10.1182/asheducation-2007.1.143
  • McNamee K, Dawood F, Farquharson RG. Thrombophilia and early pregnancy loss. Best Pract Res Clin Obstet Gynaecol. 2012;26(1):91–102. doi:10.1016/j.bpobgyn.2011.10.002
  • Arachchillage DJ, Mackillop L, Chandratheva A, Motawani J, MacCallum P, Laffan M. Thrombophilia testing: a British society for haematology guideline. Br J Haematol. 2022;198(3):443–458. doi:10.1111/bjh.18239
  • Mekaj Y, Lulaj S, Daci F, et al. Prevalence and role of antithrombin III, protein C and protein S deficiencies and activated protein C resistance in Kosovo women with recurrent pregnancy loss during the first trimester of pregnancy. J Hum Reprod Sci. 2015;8(4):224–229. PMID: 26752858. doi:10.4103/0974-1208.170407
  • Preston FE, Rosendaal FR, Walker ID, et al. Increased fetal loss in women with heritable thrombophilia. Lancet. 1996;348(9032):913–916. doi:10.1016/s0140-6736(96)04125-6
  • Alecsandru D, Klimczak AM, Velasco AG, Pirtea P, Franasiak JM. Immunologic causes and thrombophilia in recurrent pregnancy loss. Fertil Steril. 2021;115(3):561–566. doi:10.1016/j.fertnstert.2021.01.011
  • Dizon-Townson D, Miller C, Sibai B, et al. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol. 2005;106(3):517–524. doi:10.1097/01.AOG.0000173986.32528.ca
  • Hatasaka HH. Recurrent miscarriage: epidemiologic factors, definitions, and incidence. Clin Obstet Gynecol. 1994;37(3):625–634. doi:10.1097/00003081-199409000-00016
  • Scharrer I, Hach-Wunderle V, Aygoren E, et al. Frequency and clinical manifestations of congenital ptasminogen and fibrinogen deficiency compared to AT III-, PC-, and PS- deficiency in patients suffering from thromboses. Fibrin Proteolysis. 1988;2(2):16–17.
  • Barbour LA, Oja JL, Schultz LK. A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation. Am J Obstet Gynecol. 2004;191(3):1024–1029. doi:10.1016/j.ajog.2004.05.050
  • GriYn JH, GriYn JH, GriYn JH, et al. Anticoagulant protein C pathway defective in a majority of thrombophilic patients. Blood. 1993;82(7):1989–1993. doi:10.1182/blood.V82.7.1989.1989

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.